Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Wright Reports
|
$460.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Scinopharm Taiwan Ltd's Shares to Be Traded on Taiwan Stock Exchange
Scinopharm Taiwan Ltd announced that it will have its shares to be traded on Taiwan Stock Exchange from September 29, 2011, and at the same time stop the shares' trading on the emerging market.
Latest Developments for ScinoPharm Taiwan Ltd
- ScinoPharm Taiwan Ltd Announces FY 2012 Dividend Payment
- ScinoPharm Taiwan Ltd And Foresee Pharmaceuticals Announces Agreement To Establish Joint Venture For Developing Oncological Peptide Drugs
- ScinoPharm Taiwan Ltd Announces FY 2011 Dividend Payment
- Scinopharm Taiwan Ltd Announces FY 2010 Dividend Payment Date
Latest Key Developments in Pharmaceuticals
- AmerisourceBergen Corp Reaffirms FY 2013 EPS Gudiance-Conference Call
- Immunotec Inc Announces New CEO
- Novo Nordisk A/S Reports Positive Results from First Phase 3 Trial with Long-Acting Factor IX for Treatment of Haemophilia B
- Sanofi SA Announces Positive Results on Pivotal Study of Inhibitor in Myelofibrosis-DJ
- Share this
- Link this
- Digg this
Follow Reuters